(Sharecast News) - Novo Nordisk is to use artificial intelligence to help speed up research into new treatments, the Wegovy maker confirmed on Tuesday, after signing a deal with OpenAI.
Under the strategic partnership with the US tech firm, Novo Nordisk will use AI to analyse complex datasets, identify promising drug...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE